Market open

DaVita/$DVA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About DaVita

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Ticker

$DVA

Trading on

NYSE

Industry

Health Care Providers & Services

Employees

76,000

DaVita Metrics

BasicAdvanced
$11B
13.01
$10.73
1.04
-
$11B
1.04
$179.60
$130.96
868K
1.26
1.145
544.412
576.988
3.70%
7.15%
51.74%
13.007
0.926
92.8
-1.51
8.088
5.56%
44.61%
3.32%
6.43%

What the Analysts think about DaVita

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for DaVita stock.

DaVita Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

DaVita Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DVA

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs

What’s the current market cap for DaVita stock?

DaVita (DVA) has a market cap of $11B as of April 25, 2025.

What is the P/E ratio for DaVita stock?

The price to earnings (P/E) ratio for DaVita (DVA) stock is 13.01 as of April 25, 2025.

Does DaVita stock pay dividends?

No, DaVita (DVA) stock does not pay dividends to its shareholders as of April 25, 2025.

When is the next DaVita dividend payment date?

DaVita (DVA) stock does not pay dividends to its shareholders.

What is the beta indicator for DaVita?

DaVita (DVA) has a beta rating of 1.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.